Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Apply now for a free five-day programme of academic tasters, advice about applying and opportunities to meet current students

UNIQ is open to students studying in their first year of further education, who are based at UK state schools/colleges. Students make a single application between December and January and can be selected to participate in one of two activities: UNIQ Digital or UNIQ Spring and Summer.

UNIQ Spring and Summer gives you a taste of the Oxford undergraduate student experience. You will live in an Oxford college for a week, attend lectures and seminars in your chosen subject area, and receive expert advice on the Oxford application and interview process. The timetable also allows plenty of time for social activities; in the evenings you are free to tour the city, sample some of the University's sports and cultural facilities, and let your hair down at the farewell party.

UNIQ Digital provides comprehensive information and guidance on the university admissions process, and aims to give you a realistic view of Oxford student life through videos, activities and quizzes. The platform offers a range of forums where you can discuss both academic and social topics. These forums are monitored by student ambassadors, who are always on hand to answer questions and offer support.

Find out more (University of Oxford UNIQ website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.